E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/6/2006 in the Prospect News Biotech Daily.

Dade rated at sector perform by RBC

RBC Capital Markets analyst William R. Quirk rated Dade Behring Holdings, Inc. at sector perform, above average risk. An improvement in foreign exchange should add about $7.6 million to Dade's second-quarter top line results. However, the bottom line net impact will be negligible to the company's second-quarter earnings per share. RBC's 12-month price target is now $42, up from $41. Shares of the Deerfield, Ill.-based diagnostic products company were up 8 cents, or 0.20%, at $41.07 on volume of 441,141 shares versus the three-month running average of 652,613 shares. (Nasdaq: DADE)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.